SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals informs about newspaper publication

04 Dec 2025 Evaluate
Pursuant to Regulation 30 of SEBI Listing Regulation, Bharat Parenterals has enclosed copies of newspaper notice to physical shareholder published on December 04, 2025 in the following newspaper, informing about the opening of a special window for relodgments of transfer requests for physical shares, which were lodged prior to the deadline of April 01, 2019 and rejected/returned due to deficiencies in the documents, in accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSDPoD/P/CIR/2025/97 dated July 02, 2025: 1. Business Standard (English), 2. Vadodara Samachar (Gujarati). The advertisement is also being made available on the Company’s website at www.bplindia.in

The above information is a part of company’s filings submitted to BSE.

Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×